169 related articles for article (PubMed ID: 25491173)
1. Pirfenidone prevents rat esophageal stricture formation.
Orozco-Perez J; Aguirre-Jauregui O; Salazar-Montes AM; Sobrevilla-Navarro AA; Lucano-Landeros MS; Armendáriz-Borunda J
J Surg Res; 2015 Apr; 194(2):558-564. PubMed ID: 25491173
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of single-dose 5-fluorouracil therapy in experimental caustic esophageal burn.
Duman L; Büyükyavuz BI; Altuntas I; Gökcimen A; Ceyhan L; Darici H; Aylak F; Tomruk O
J Pediatr Surg; 2011 Oct; 46(10):1893-7. PubMed ID: 22008323
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of Ankaferd Blood Stopper on caustic esophageal injuries: an experimental model.
Akbal E; Köklü S; Karaca G; Astarci HM; Koçak E; Taş A; Beyazit Y; Topcu G; Haznedaroğlu IC
Dis Esophagus; 2012 Apr; 25(3):188-94. PubMed ID: 21819483
[TBL] [Abstract][Full Text] [Related]
4. Pirfenidone prevents esophageal stricture by inhibiting nucleotide binding oligomerization domain like receptor protein 3 inflammasome activation.
Hirano S; Higashimori A; Nagami Y; Nadatani Y; Tanigawa T; Ominami M; Fukunaga S; Otani K; Hosomi S; Tanaka F; Kamata N; Taira K; Watanabe T; Fujiwara Y
J Gastroenterol Hepatol; 2022 Jun; 37(6):1096-1106. PubMed ID: 35434849
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral tamoxifen on the healing of corrosive oesophageal burns in an experimental rat model.
Elmas O; Cevik M; Demir T; Ketani MA
Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):351-6. PubMed ID: 24893869
[TBL] [Abstract][Full Text] [Related]
6. Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells.
Zhao XY; Zeng X; Li XM; Wang TL; Wang BE
Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):963-8. PubMed ID: 19413596
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of dexpanthenol and y-27632 on stricture formation in a rat model of caustic esophageal injury.
Ceylan H; Yapici S; Tutar E; Ceylan NO; Tarakçıoğlu M; Demiryurek AT
J Surg Res; 2011 Dec; 171(2):517-23. PubMed ID: 20691993
[TBL] [Abstract][Full Text] [Related]
8. Effects of Pirfenidone and Collagen-Polyvinylpyrrolidone on Macroscopic and Microscopic Changes, TGF-
Olmos-Zuñiga JR; Silva-Martínez M; Jasso-Victoria R; Baltazares-Lipp M; Hernández-Jiménez C; Buendía-Roldan I; Jasso-Arenas J; Martínez-Salas A; Calyeca-Gómez J; Guzmán-Cedillo AE; Gaxiola-Gaxiola M; Romero-Romero L
Biomed Res Int; 2017; 2017():6471071. PubMed ID: 28584818
[TBL] [Abstract][Full Text] [Related]
9. Cordycepin prevents the esophageal stricture formation in the alkali-burn rat model by exerting anti-inflammatory and antifibrotic effects.
Ercan G; Altinel Y; Karagulle OO; Yiğitbaş H; Hacım NA; Meriç S; Buğdaycı N; Tartar RI; Biltekin B; Yavuz E; Gulcicek OB; Solmaz A; Çelik A
Acta Cir Bras; 2021; 36(3):e360302. PubMed ID: 33729331
[TBL] [Abstract][Full Text] [Related]
10. Effects of caffeic acid phenethyl ester and epidermal growth factor on the development of caustic esophageal stricture in rats.
Koltuksuz U; Mutuş HM; Kutlu R; Ozyurt H; Cetin S; Karaman A; Gürbüz N; Akyol O; Aydin NE
J Pediatr Surg; 2001 Oct; 36(10):1504-9. PubMed ID: 11584397
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of ibuprofen against caustic esophageal burn injury in rats.
Herek O; Karabul M; Yenisey C; Erkuş M
Pediatr Surg Int; 2010 Jul; 26(7):721-7. PubMed ID: 20480167
[TBL] [Abstract][Full Text] [Related]
12. Role of caffeic acid phenethyl ester, an active component of propolis, against NAOH-induced esophageal burns in rats.
Ocakci A; Kanter M; Cabuk M; Buyukbas S
Int J Pediatr Otorhinolaryngol; 2006 Oct; 70(10):1731-9. PubMed ID: 16828884
[TBL] [Abstract][Full Text] [Related]
13. Trimetazidine reduces the degree of fibrosis in alkali burns of the esophagus.
Yukselen V; Karaoglu AO; Yenisey C; Tuncyurek M; Ozutemiz O
J Pediatr Surg; 2005 Mar; 40(3):505-9. PubMed ID: 15793726
[TBL] [Abstract][Full Text] [Related]
14. Prevention of esophageal strictures in a caustic burn model using halofuginone, an inhibitor of collagen type I synthesis.
Arbell D; Udassin R; Koplewitz BZ; Ohana M; Genina O; Pines M; Nagler A
Laryngoscope; 2005 Sep; 115(9):1632-5. PubMed ID: 16148708
[TBL] [Abstract][Full Text] [Related]
15. The preventive effect of heparin on stricture formation after caustic esophageal burns.
Bingöl-Kologlu M; Tanyel FC; Müftüoğlu S; Renda N; Cakar N; Büyükpamukçu N; Hiçsönmez A
J Pediatr Surg; 1999 Feb; 34(2):291-4. PubMed ID: 10052807
[TBL] [Abstract][Full Text] [Related]
16. Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity.
Shihab FS; Bennett WM; Yi H; Andoh TF
Am J Transplant; 2002 Feb; 2(2):111-9. PubMed ID: 12099512
[TBL] [Abstract][Full Text] [Related]
17. A novel approach for preventing esophageal stricture formation: sphingosylphosphorylcholine-enhanced tissue remodeling.
Yagmurlu A; Aksu B; Bingol-Kologlu M; Renda N; Altinok G; Fitoz S; Gokcora IH; Dindar H
Pediatr Surg Int; 2004 Oct; 20(10):778-82. PubMed ID: 15185106
[TBL] [Abstract][Full Text] [Related]
18. Topical application of basic fibroblast growth factor reduces esophageal stricture and esophageal neural damage after sodium hydroxide-induced esophagitis in rats.
Okata Y; Hisamatsu C; Nishijima E; Okita Y
Pediatr Surg Int; 2012 Jan; 28(1):43-9. PubMed ID: 22009209
[TBL] [Abstract][Full Text] [Related]
19. Low dose pirfenidone suppresses transforming growth factor beta-1 and tissue inhibitor of metalloproteinase-1, and protects rats from lung fibrosis induced by bleomycina.
Tian XL; Yao W; Guo ZJ; Gu L; Zhu YJ
Chin Med Sci J; 2006 Sep; 21(3):145-51. PubMed ID: 17086734
[TBL] [Abstract][Full Text] [Related]
20. Anti-fibrotic action of pirfenidone in Dupuytren's disease-derived fibroblasts.
Zhou C; Liu F; Gallo PH; Baratz ME; Kathju S; Satish L
BMC Musculoskelet Disord; 2016 Nov; 17(1):469. PubMed ID: 27835939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
